Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Brineworks | 2025 | Seed | $8.0M | Amsterdam |
| MiMARK | 2025 | Seed | $394K | Barcelona |
| Melt&Marble | 2025 | Venture - Series Unknown | $3.2M | Göteborg |
| Better Medicine | 2025 | Pre-Seed | $1.2M | Tartu |
| QuiX | 2025 | Series A | $17.5M | Amsterdam |
| SiPearl | 2025 | Series A | $37.6M | Maisons-laffitte |
| Plasmacure | 2025 | Series A | $7.1M | Eindhoven |
| Scope Biosciences | 2025 | Seed | $1.2M | Wageningen |
| Lumoview Building Analytics | 2025 | Seed | $3.4M | Cologne |
| ecop Technologies GmbH | 2025 | Venture - Series Unknown | $12.0M | Neuhofen An Der Krems |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Brineworks | Seed | $8.0M | Amsterdam, The Netherlands |
| 127 | MiMARK | Seed | $394K | Barcelona, Spain |
| 128 | Melt&Marble | Venture - Series Unknown | $3.2M | Göteborg, Sweden |
| 129 | Better Medicine | Pre-Seed | $1.2M | Tartu, Estonia |
| 130 | QuiX | Series A | $17.5M | Amsterdam, The Netherlands |
| 131 | SiPearl | Series A | $37.6M | Maisons-laffitte, France |
| 132 | Plasmacure | Series A | $7.1M | Eindhoven, The Netherlands |
| 133 | Scope Biosciences | Seed | $1.2M | Wageningen, The Netherlands |
| 134 | Lumoview Building Analytics | Seed | $3.4M | Cologne, Germany |
| 135 | ecop Technologies GmbH | Venture - Series Unknown | $12.0M | Neuhofen An Der Krems, Austria |
Brineworks develops direct air capture technology for various carbon dioxide applications.
MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.
Melt&Marble, formerly known as Biopetrolia, was founded patent holding firm for co-founder Professor Jens Nielsen’s research group.
Better Medicine focuses advancing medical care through the latest innovations in AI and medical imaging
QuiX develops photonic quantum computing hardware, utilizing integrated photonics to process quantum information through light particles.
SiPearl designs European high-performance energy-efficient processors for supercomputing and AI
Plasmacure is a medical device to cure advanced wounds.
Scope Biosciences is a on-site development platform technology specializing in the development of molecular diagnostics using CRISPR-Cas.
Lumoview digitizes buildings in 2 seconds per room and empowers owners to improve their buildings and reduce CO2 emissions.
ecop is a high-tech company that manufactures rotation heat pumps for industrial use using a novel, multi-patented technology.
Esencia Foods is a food and beverages company that makes vegan meat from mycelium solid state fermentation.
SemiQon develops semiconductor technologies that focus on energy-efficient chips for quantum computing and high-performance applications.
Invitris is a biotech company that develops protein-based drugs.
CarbonX develops and supplies new materials to design the next generation of materials.
OQ Technology provides ubiquitous global network coverage for the next unconnected 50 billion IoT devices and machines
Laclaree develops a pair of adaptive eyeglasses for presbyopia.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
Mindpeak develops and distributes AI-based diagnostic software for the detection, quantification, and classification of cancer.
Morphotonics is a provider of nanoimprint and microreplication technology solution.
DcubeD develops actuators and deployable structures tailored for nano-satellites and the commercial space industry.
NoPalm Ingredients produces sustainable microbial oils to replace the use of palm- and other tropical oils in food and cosmetics.
Pharrowtech designs next-generation solutions for fixed-wireless access, wireless VR/AR and ultra-high capacity wireless links.
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
Wave Photonics utilizes computational techniques to accelerate integrated photonics product designs.
Iris.ai provides an AI science assistant that helps R&D departments navigate and find research text content.
EIC Accelerator has invested in 315 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EIC Accelerator's top investment sectors include Biotechnology, Health Care, Food Processing, Medical, Hardware. The firm invests across 52 different industry categories.
Among tracked funding rounds, SiPearl received $37.6M in a Series A round. EIC Accelerator's total known invested capital is $1.4B.
EIC Accelerator's average investment size is $5.0M across its portfolio of 315 companies.
Recent EIC Accelerator portfolio additions include Brineworks, MiMARK, Melt&Marble, Better Medicine, QuiX. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors